Charles Makin
Director
Mapi HEOR and Strategic Market Access, USA
Charles has served as Principal Investigator on a large number of global retrospective database studies, registries, patient/physician surveys, systematic literature reviews, economic models, and value strategy development in many therapeutic areas, including cardiovascular, central nervous system, oncology, diabetes, respiratory, rheumatology, dermatology, infectious diseases and others. He has authored over 60 peer-reviewed manuscripts and scientific presentations.
My research interests lie primarily in the areas of comparative effectiveness research, resource utilization and costs associated with diseases (burden of illness) and interventions, health technology assessment and patient-reported outcomes.
Epilepsy Journal received 41 citations as per Google Scholar report